MedPath

Health benefits of pulses (legumes) in older overweight adults

Not Applicable
Completed
Conditions
Cognitive function
Cardiometabolic health
obesity
Diet and Nutrition - Obesity
Cardiovascular - Other cardiovascular diseases
Mental Health - Studies of normal psychology, cognitive function and behaviour
Registration Number
ACTRN12611000642987
Lead Sponsor
Associate Professor Jon Buckley
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
160
Inclusion Criteria

overweight/obese (BMI > 25kg/m2), older adults (age 50-80 years) who consume one or less serves per week of pulses.

Exclusion Criteria

1. Body weight exceeding 135kg (maximum capacity of the DEXA scanner) 2.Established cardiovascular, liver or kidney disease 3.Uncontrolled diabetes 4. Use of medication or supplements for management of elevated lipids, blood pressure or glucose that has not been stable for at least 3 months, other medication will be considered at the discretion of the investigators 5.Use of appetite suppressants or Orlistat (Xenical) 6.Inability to consume pulse-enriched foods 7.Pregnancy 8.Smoking or only recently quit smoking (within the last 12 months) 9.Weight loss of 3kg or more in the 6 months prior to enrolling in the study 10.Adherence to a weight loss diet or physical activity program designed to facilitate weight loss 11.Acute or terminal illness 12. Alcohol consumption of more than 4 standard drinks per day.13. Prostheses or implants that are considered by the investigators to influence the accuracy of the body composition scan

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cerebral vasodilator responsiveness will be measured by Transcranial Doppler (TCD)[Baseline (week 0), week 6 and week 12]
Secondary Outcome Measures
NameTimeMethod
Body composition will be assessed by dual energy x-ray absorptiometry (DEXA, specifically fat and lean mass), weight, waist and hip circumference[Baseline (week 0), week 6 and week 12];Arterial compliance and blood pressure will be assessed by the cardiovascular profiler and automatic sphygmomanometer, respectively.[Baseline (week 0), week 6 and week 12];Lipids and lipoproteins will be assessed by serum analysis[Baseline (week 0), week 6 and week 12];Insulin sensitivity will be assessed by serum analysis[Baseline (week 0), week 6 and week 12];Cognitive function will be assessed by a battery of tests including the Rey Auditory Verbal Learning Test (RAVLT), Wechsler Adult Intelligence Scale (WAIS) IV, Controlled Oral Word Association (COWA) and Stroop[Baseline (week 0), week 6 and week 12]
© Copyright 2025. All Rights Reserved by MedPath